Heart Failure Patients Who Improve See Lower Risk of Worsening, but Shouldn’t Stop Medication, study Finds
New York, NY – Patients diagnosed with heart failure who experience an advancement in their heart’s ejection fraction face a significantly lower risk of disease progression compared to those whose condition remains stable, according to a new study published in the Journal of the American College of Cardiology (JACC). However, researchers emphasize that discontinuing prescribed medication is linked to increased risk, particularly hospitalization.
The large-scale study,analyzing data from over 28,000 patients diagnosed with heart failure with reduced ejection fraction between 2013 adn 2022,revealed that approximately 30% of patients saw their ejection fraction improve within one year of diagnosis. This improvement was more common in younger individuals, with an average age of 66, and was associated with higher rates
